Read news on ADC with our app.
Read more in the app
ADC improves outcomes for patients with advanced triple-negative breast cancer who are ineligible for immune checkpoint inhibitors - EurekAlert!
ASCO: HER3-targeted antibody-drug conjugate (ADC) shows promise for treatment-resistant solid tumors - EurekAlert!
